Cisplatin Exhibits Superiority over MMC as a Perfusion Agent in a Peritoneal Mesothelioma Patient Specific Organoid HIPEC Platform

The authors applied peritoneal mesothelioma patient-derived tumor organoids in elucidating personalized hyperthermic intraperitoneal chemotherapy (HIPEC) responses to bypass rarity of disease in generating preclinical data.